research on glp 1 drugs Discovery of GLP-1–Based for the Treatment of Obesity GLP-1 Receptor Agonists Obesity Drugs
Description
This is just a glimpse of the GLP-1 insights available to CivicScience clients
India Issues Urgent GLP-1 Drug Safety Alert The Indian Pharmacopoeia Commission (IPC) has issued a public notice on 14 May calling on doctors, patients, and consumers to closely monitor and report any adverse reactions linked to semaglutide and other GLP-1 receptor agonists including dulaglutide, liraglutide, and tirzepatide
A Breakthrough Award, New Evidence in Parkinson's and Heart Disease
Clinicians should maintain heightened awareness for aspiration risk in perioperative settings
The problem is what the studies actually show.
